Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension

NCT02893995 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Slow Dose Titration Group of Subcutaneous Treprostinil
DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil

Sponsor

United Therapeutics

Collaborators

[object Object]